Status:
COMPLETED
SURgical Outcomes in COvid Patients - the SUROCO Multicenter Cohort Study (COVID-19)
Lead Sponsor:
Centre hospitalier de l'Université de Montréal (CHUM)
Collaborating Sponsors:
Maisonneuve-Rosemont Hospital
Centre de recherche du Centre hospitalier universitaire de Sherbrooke
Conditions:
Covid-19
SARS-CoV2
Eligibility:
All Genders
Brief Summary
Overall mortality of COVID-19 is variable and has been reported to be between less than 1% and 7%. Many authors around the world also reported data on hospitalization rate, need for intensive care uni...
Detailed Description
METHODS Objectives Primary: To describe postoperative outcomes in patients with COVID-19 undergoing a surgical procedure and measure the association between presence of symptoms and postoperative out...
Eligibility Criteria
Inclusion
- all patients undergoing a surgery with either a SARS-CoV-2 clinical suspicion based on reported symptoms during the pandemic (fever, myalgia, fatigue, cough, dyspnea, respiratory failure, diarrhea, vomiting, abdominal pain) or without any suggestive symptoms AND a SARS-CoV-2 confirmed infection with RT-PCR before surgery or within 72 hours after surgery. Patients who have recovered from SARS-CoV-2 infection will also be included. All patients up to 30th day of April 2021 will be included.
Exclusion
- none
Key Trial Info
Start Date :
March 13 2020
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
April 13 2022
Estimated Enrollment :
318 Patients enrolled
Trial Details
Trial ID
NCT04458337
Start Date
March 13 2020
End Date
April 13 2022
Last Update
July 12 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Centre Hospitalier de l'Université de Montréal (CHUM)
Montreal, Quebec, Canada, H2X 3E4